MedPath

National Database of the Virtual Institute of Cerebrovascular Diseases

Not yet recruiting
Conditions
Cerebrovascular Disease
Interventions
Other: Collection of clinical, radiological, and biological data from patients' medical records
Registration Number
NCT05925699
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The primary aim of the study is to develop a national registry of cerebrovascular diseases in order to define the subtypes of these diseases associated with a worse prognosis. Secondly, the study aims to find clinical, radiological, and biological markers capable tof predicting the outcome of cerebrovascular diseases and the onset of complications related to therapeutic procedures, and to calculate predictive prognostic scores composed of multiple variables.

Each participating center will collect clinical, radiological, and biological data from the medical records of the study participants. Patients included in the study will not undergo any additional medical procedures to those of normal clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
285600
Inclusion Criteria
  • Diagnosis of cerebrovascular pathology defined according to the NINDS special report of 1990 as "all disorders in which there is an area of the brain transiently or permanently affected by ischemia or bleeding and/or in which one or more blood vessels of the brain are mainly altered by a pathological process", falling within the following codes of the International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438;
  • Informed consent provided by the patient or his legal representative in the case of mental incapacity or by the parents/guardians in the case of minors.
Exclusion Criteria
  • The patient, his legal representative in the case of mental incapacity or his parents/guardians in the case of minors clearly state their will to leave the study;
  • Onset of cerebrovascular disease before January 1, 2016.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
All patients with new-onset cerebrovascular disease from January 1, 2016 to July 1, 2049Collection of clinical, radiological, and biological data from patients' medical records-
Primary Outcome Measures
NameTimeMethod
Identification of subtypes of each cerebrovascular disease (ICD-9 430-438) associated with poor prognosis.July 1, 2023 - July 1, 2053

Identification and definition of the various subtypes of each cerebrovascular disease (International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438) associated with poor prognosis.

Secondary Outcome Measures
NameTimeMethod
Identification of radiological variables of each cerebrovascular disease able to predict the success of pharmacological or procedural therapiesJuly 1, 2023 - July 1, 2053

Identification of radiological variables of each cerebrovascular disease able to predict the success of pharmacological or procedural therapies

Identification of neurophysiological variables of each cerebrovascular disease helping in differential diagnosisJuly 1, 2023 - July 1, 2053

Identification of neurophysiological variables and biomarkers of each cerebrovascular disease helping in differential diagnosis

Identification of clinical variables of each cerebrovascular disease capable of predicting the development of complicationsJuly 1, 2023 - July 1, 2053

Identification of clinical variables of each cerebrovascular disease capable of predicting the development of spontaneous complications or complications related to therapeutic procedures

Identification of radiological variables of each cerebrovascular disease helping in differential diagnosisJuly 1, 2023 - July 1, 2053

Identification of radiological variables of each cerebrovascular disease helping in differential diagnosis

Identification of neurophysiological variables of each cerebrovascular disease capable of predicting the development of complicationsJuly 1, 2023 - July 1, 2053

Identification of neurophysiological variables of each cerebrovascular disease capable of predicting the development of complications

Identification of radiological variables of each cerebrovascular disease capable of predicting the development of complicationsJuly 1, 2023 - July 1, 2053

Identification of radiological variables of each cerebrovascular disease capable of predicting the development of complications

Identification of biomarkers of each cerebrovascular disease helping in differential diagnosisJuly 1, 2023 - July 1, 2053

Identification of biomarkers of each cerebrovascular disease helping in differential diagnosis

Identification of clinical variables of each cerebrovascular disease correlated with its prognosisJuly 1, 2023 - July 1, 2053

Identification of the clinical variables of each cerebrovascular disease correlated with its prognosis

Identification of radiological variables of each cerebrovascular disease correlated with its prognosisJuly 1, 2023 - July 1, 2053

Identification of the radiological variables of each cerebrovascular disease correlated with its prognosis

Identification of neurophysiological variables of each cerebrovascular disease correlated with its prognosisJuly 1, 2023 - July 1, 2053

Identification of the neurophysiological variables of each cerebrovascular disease correlated with its prognosis

Identification of prognostic scores for each cerebrovascular diseaseJuly 1, 2023 - July 1, 2053

Identification of prognostic scores for each cerebrovascular disease, based on the combination of clinical, radiological, neurophysiological and biomarker variables

Identification of biomarkers of each cerebrovascular disease capable of predicting the development of complicationsJuly 1, 2023 - July 1, 2053

dentification of biomarkers of each cerebrovascular disease capable of predicting the development of complications

Identification of biomarkers of each cerebrovascular disease able to predict the success of pharmacological or procedural therapiesJuly 1, 2023 - July 1, 2053

Identification of biomarkers of each cerebrovascular disease able to predict the success of pharmacological or procedural therapies

Identification of biomarkers of each cerebrovascular disease correlated with its prognosisJuly 1, 2023 - July 1, 2053

Identification of the biomarkers of each cerebrovascular disease correlated with its prognosis

Identification of clinical variables of each cerebrovascular disease helping in differential diagnosisJuly 1, 2023 - July 1, 2053

Identification of clinical variables of each cerebrovascular disease that help the clinician in early differential diagnosis

Identification of clinical variables of each cerebrovascular disease able to predict the success of pharmacological or procedural therapiesJuly 1, 2023 - July 1, 2053

Identification of clinical variables of each cerebrovascular disease able to predict the success of pharmacological or procedural therapies

Identification of the clinical variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcomeJuly 1, 2023 - July 1, 2053

Identification of the clinical variables of each cerebrovascular disease useful for the purpose of personalizing the rehabilitation treatment and able to predict the good functional outcome following the same rehabilitation treatments

Identification of the radiological variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcomeJuly 1, 2023 - July 1, 2053

Identification of the radiological variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome

Identification of the neurophysiological variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcomeJuly 1, 2023 - July 1, 2053

Identification of the neurophysiological variables of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome

Identification of the biomarkers of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcomeJuly 1, 2023 - July 1, 2053

Identification of the biomarkers of each cerebrovascular disease useful for the personalization of the rehabilitation treatment and able to predict its functional outcome

Trial Locations

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

🇮🇹

Rome, Lazio, Italy

© Copyright 2025. All Rights Reserved by MedPath